查看文章

We thank Yang et al 1 for their comments with an updated metaanalysis to our research article ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’. 2 Their findings contribute to accurate elaboration and substantiation of our findings. Yang et al 1 undertook an updated meta-analysis, including studies that were reported after our article was published, and found that patients with autoimmune diseases had a significantly increased risk of mortality compared with those without. This is in contrast to our results which showed no such increased risk. This difference is likely due to the larger number of publications and patients included in their updated meta-analysis. Indeed, there are a growing number of patients with autoimmune diseases who had SARS-CoV-2 infection being reported. Since the COVID-19 Global Rheumatology Alliance was …